This inventor holds 1 USPTO granted patent. Top assignee: Bayer Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Jane F. Wallace: Innovator in Analyte Determination
Introduction
Jane F. Wallace is a notable inventor based in South Bend, IN (US). She has made significant contributions to the field of fluid sample analysis, particularly in improving the accuracy of analyte determination. Her innovative approach has the potential to enhance clinical testing and diagnostics.
Latest Patents
Jane F. Wallace holds 1 patent for her invention titled "Method for improving the accuracy of the semi-quantitative determination of analyte in fluid samples." This patent discloses an improved method for determining the concentration of a first analyte in a fluid test sample as a function of a second analyte present in the sample. The method involves determining the concentration of the first analyte and, if this concentration is outside of its useful analytical range, dividing it by the normal concentration of the second analyte. This innovative ratioing method increases accuracy and reduces the occurrence of false positive and false negative results.
Career Highlights
Jane is currently associated with Bayer Corporation, where she applies her expertise in analytical methods. Her work focuses on enhancing the reliability of fluid sample testing, which is crucial for accurate clinical assessments.
Collaborations
Some of her notable coworkers include Michael J. Pugia and Koleen K. Messenger. Their collaborative efforts contribute to the advancement of research and development in the field of analyte determination.
Conclusion
Jane F. Wallace's contributions to the field of fluid sample analysis exemplify the impact of innovative thinking in clinical diagnostics. Her patented method not only improves accuracy but also enhances the reliability of test results, making a significant difference in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
